| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.0091 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.005 | 1 |